$0.776900
0.011.56%
At close: -
$0.740300
-0.04-4.71%
After Hours: 5:03 PM EDT
Comments
Loading...
ProPhase Labs (PRPH) Forecast
NewsEarningsProPhase Labs (PRPH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProPhase Labs (NASDAQ:PRPH) Stock Quotes, Forecast and News Summary
ProPhase Labs Stock (NASDAQ: PRPH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ProPhase Labs (PRPH) stock?
You can purchase shares of ProPhase Labs (NASDAQ:PRPH) through any online brokerage.
Who are ProPhase Labs (PRPH) competitors?
Other companies in ProPhase Labs’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the forecast, or price target, for ProPhase Labs (PRPH) stock?
ProPhase Labs has a consensus price target of $11.00.
What is the current price for ProPhase Labs (PRPH)?
The stock price for ProPhase Labs (NASDAQ: PRPH) is $0.7403 last updated November 21, 2024 at 5:03 PM EST.
Does ProPhase Labs (PRPH) pay a dividend?
A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on June 3, 2022 to stockholders of record on May 24, 2022.
When is ProPhase Labs (NASDAQ:PRPH) reporting earnings?
ProPhase Labs’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is ProPhase Labs (PRPH) going to split?
There is no upcoming split for ProPhase Labs.
What sector and industry does ProPhase Labs (PRPH) operate in?
ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.